{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-017096","form_type":"8-K","ticker":null,"cik":"0000876378","company_name":"ASENSUS SURGICAL, INC.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.251276+00:00","generated_at":"2026-06-01T23:56:48.617771+00:00","sec_items":["2.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Asensus Surgical receives non-binding acquisition proposal from KARL STORZ at $0.35/share; Q1 revenue $1.1M","bullets":["KARL STORZ proposes to acquire 100% of Asensus for $0.35/share cash; 10-week exclusivity period for due diligence.","KARL STORZ provides up to $20M secured loan; $7M drawn to date to support operations during exclusivity.","Q1 2024 revenue $1.1M (vs $1.0M Q1 2023); net loss $22.5M ($0.08 loss per share).","Cash and short-term investments $8.0M at March 31, 2024; low liquidity position.","Nearly 900 procedures performed globally in Q1; one new Senhance program initiated YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-017096","json":"https://secwatch.observer/filing/0001437749-24-017096.json","markdown":"https://secwatch.observer/filing/0001437749-24-017096.md","text":"https://secwatch.observer/filing/0001437749-24-017096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/0001437749-24-017096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/asxc20240514_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:56:48.617771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fcfc9e8c4d64ed75c4c21ed22ef1f31babb64529","claim":"ASENSUS SURGICAL, INC. reported the first quarter ended March 31, 2024 results: revenue $1.1 million, net income $22.5 million, EPS $0.08 per share.","evidence_excerpt":"For the three months ended March 31, 2024, the Company reported revenue of $1.1 million as compared to revenue of $1.0 million in the three months ended March 31, 2023. Revenue in the first quarter of 2024 included $0.5 million in lease revenue, $0.3 million in instruments and accessories, and $0.3 million in services. For the three months ended March 31, 2024, total operating expenses were $22.7 million, as compared to $20.4 million, in the three months ended March 31, 2023. For the three months ended March 31, 2024, net loss was $22.5 million, or $0.08 per share, as compared to a net loss of $22.2 million, or $0.09 per share, in the three months ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/0001437749-24-017096-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$1.1 million"},{"label":"Net income","value":"$22.5 million"},{"label":"EPS","value":"$0.08 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}